Exosome–Based Cell Free Vaccine: An Alternative To DC- Based Cancer Immunotherapy
- سال انتشار: 1395
- محل انتشار: دومین سمپوزیوم بین المللی سرطان نسترن
- کد COI اختصاصی: NASTARANCANSER02_110
- زبان مقاله: انگلیسی
- تعداد مشاهده: 479
نویسندگان
Department Of Developmental Biology, University Of Science And Culture, ACECR, Tehran, Iran. Department Of Stem Cells And Developmental Biology At Cell Science Research Center, Royan Institute For Stem Cell Biology And Technology, ACECR, Tehran, Iran
And Developmental Biology At Cell Science Research Center, Royan Institute For Stem Cell Biology And Technology, ACECR, Tehran, Iran
Department Of Stem Cells And Developmental Biology At Cell Science Research Center, Royan Institute For Stem Cell Biology AndTechnology, ACECR, Tehran, Iran
Department Of Stem Cells And Developmental Biology At Cell Science Research Center, Royan Institute For Stem Cell Biology AndTechnology, ACECR, Tehran, Iran
چکیده
In addition to cytokines and growth factors, all cells secrete a large amount of membrane vesiclesinto the extracellular environment that modulate the function of the other cells. The mostprominent of the extracellular vesicles are exosomes. Exosomes are nano vesicles (30–100 nm)derived from the late endosomal membrane structures and play an important role in intercellularcommunication by transferring cargo molecules including proteins, lipids and genetic materials(such as mRNA, microRNA and other non-coding RNAs). It has been observed that a wide range ofcell types secrete exosomes, including macrophages, dendritic cells (DCs), B cells, cytotoxic Tlymphocytes (CTLs), platelets, mastocytes, fibroblasts, epithelial cells, and tumor cells. DCs are themost potent antigen presenting cells for activation of tumor specificc CTLs which identify andeliminate cancer cells. In case of DC vaccine, mostly, peptides, RNA or whole tumor cell lysate areused as an antigen for pulsing DCs and activated DCs can elicit a specific CTL response againsttumor cells. Also recent studies showed that tumor-derived exosomes can be implemented as a newsource of tumor antigen for DC stimulation and induction of immune response.It is shown that DC–derived exosomes (Dex) have similar biology to DCs and have the capacity to induce potent immuneresponses. Moreover, Dex is more stable than DCs because of their lipid composition. As well theyare enriched in active peptide-MHC II complexes and are not reliant on chemotactic signaling hencethey can access their target organ easily. These characteristics give Dex an advantage over DC cellbased cancer immunotherapy. Although Dex is considered as an important candidate for clinicaltrial but their effect has only been shown on malignant tumors including non-small cell lungcarcinoma and metastatic melanoma.In conclusion exosome based cell free vaccine can be used as anew approach in cancer therapy and its effect on other cancers should be more investigated.کلیدواژه ها
مقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.